ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 112 filers reported holding ENZO BIOCHEM INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $512,000 | -5.2% | 98,602 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $540,000 | +7.8% | 98,602 | +60.3% | 0.01% | +25.0% |
Q4 2017 | $501,000 | -22.2% | 61,500 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $644,000 | -17.2% | 61,500 | -12.8% | 0.01% | -14.3% |
Q2 2017 | $778,000 | +10.8% | 70,500 | -16.0% | 0.01% | 0.0% |
Q1 2017 | $702,000 | +20.6% | 83,900 | 0.0% | 0.01% | +16.7% |
Q4 2016 | $582,000 | +36.3% | 83,900 | 0.0% | 0.01% | +50.0% |
Q3 2016 | $427,000 | – | 83,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 1,047,732 | $5,333,000 | 2.30% |
KOPP INVESTMENT ADVISORS LLC | 232,099 | $1,181,000 | 1.17% |
GLOBEFLEX CAPITAL L P | 225,834 | $1,149,000 | 0.29% |
KEMPNER CAPITAL MANAGEMENT INC. | 70,001 | $356,000 | 0.24% |
Breithorn Capital Management | 63,324 | $322,000 | 0.24% |
Acrospire Investment Management LLC | 55,444 | $282,000 | 0.19% |
EAM Investors, LLC | 267,368 | $1,361,000 | 0.18% |
Granahan Investment Management | 875,002 | $4,454,000 | 0.15% |
Geduld E E | 15,000 | $76,000 | 0.08% |
GILDER GAGNON HOWE & CO LLC | 872,009 | $4,439,000 | 0.08% |